bigfoot biomedical Archives - MedCity News

Abbott-Bigfoot Deal Proves That Diabetes Is a Hot Area for Digital Health Investment

Katie Adams — Thu, 07 Sep 2023 20:17:35 +0000

This week, Abbott announced its plans to acquire Bigfoot Biomedical — a startup selling a “smart” insulin pen cap, which collects data from a user’s CGM to help them calculate the right dose. Most analysts were unsurprised to hear of the acquisition given that the two companies have been collaborating for more than six years, but they said the deal reinforces the steady pace of digital innovation in the diabetes care space.

Bigfoot Biomedical gets FDA clearance for ‘smart’ insulin pen caps

Elise Reuter — Wed, 12 May 2021 17:54:07 +0000

The startup received 510(k) clearance for its “smart” insulin pen cap, which pulls in data from users’ connected glucose monitor to help them calculate the right dose.

With $55M in new funding, Bigfoot Biomedical takes strides toward FDA submission

Elise Reuter — Thu, 04 Jun 2020 00:00:50 +0000

Bigfoot Biomedical plans to submit an application to the FDA for clearance of its smart insulin pen caps this month. The devices pull in information from a connected glucose monitor to help users calculate the optimal insulin with each meal.

Bigfoot Biomedical lands $45M as it readies first diabetes product

Joel Berg — Thu, 16 Jan 2020 00:01:11 +0000

The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.

Rock Health: Digital health investing has already surpassed record-breaking 2017

Kevin Truong — Mon, 01 Oct 2018 19:59:21 +0000

In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.

Bigfoot brings in $55M Series B to propel integrated diabetes platform

Josh Baxt — Thu, 29 Mar 2018 18:56:00 +0000

The California startup is attempting to create a closed-loop and integrated diabetes platform that attracted Abbott, whic has been a partner since July to invest.

Bigfoot Biomedical closes $37M Series B as it prepares for clinical trials of insulin delivery tech

Stephanie Baum — Thu, 21 Dec 2017 21:50:28 +0000

Bigfoot Biomedical CEO Jeffrey Brewer said in an email that the company expects to begin pivotal trials in the second half of 2018.

From Bigfoot Biomedical’s artificial pancreas to the athenahealth accelerator: 5 must-read stories from MedCity News this week

Nicole Oran — Sat, 16 May 2015 10:55:31 +0000

On MedHeads Friday, we covered everything from Dr. Patrick Soon-Shiong’s continued funding for NantBioscience, our […]

Bigfoot Biomedical’s artificial pancreas is emerging from hack mode with a $15M Series A in the works

Meghana Keshavan — Wed, 13 May 2015 20:26:59 +0000

Bigfoot Biomedical is building an artificial pancreas, combining continuous glucose monitor tech with an insulin pump – and raising some capital to do so.